PSYC Begins Audit of 2021 Financials
April 19 2022 - 8:30AM
InvestorsHub NewsWire
PSYC Begins Audit of 2021
Financials
LAKE OSWEGO, OR -- April 19, 2022 --
InvestorsHub NewsWire -- PSYC Corporation
(OTCPink:
PSYC) (“PSYC” or the “Company”) a media leader for the emerging
sector of medicinal psychedelics and authorities behind Psychedelic
Spotlight, a top ranking psychedelic news and
information platform, is pleased to announce that on the heels of
successfully completing the audit of its 2020 financials last
month, the Company has now commenced with the audit of its 2021
financials.
M&K CPAS, PLLC will once again serve as the
auditing firm for the Company, who is eager to bring its audited
financial statements current through December 31, 2021. Thereafter,
it is the Company’s intention to maintain current and fully audited
financials on a quarterly basis as it continues working towards,
but cannot guarantee, an eventual up listing to the OTCQB by way of
filing its Form-10 registration
statement.
“Swiftly moving into the audit of our 2021
financials, after successfully completing our 2020 audit,
represents another example of our unwavering commitment to keeping
PSYC on track for a potential up listing from the pink sheets to
the OTCQB in the most reasonable time frame possible,” said PSYC
CEO, David Flores. “Up listing is something we continue to view as
an essential part of the credibility and overall value we are
determined to establish for PSYC and our shareholders in the months
and years ahead. We look forward to tackling the 2021 audit while
simultaneously solidifying key objectives, such as our monetization
strategies, that we believe are equally important to PSYC’s growth
potential.”
PSYC CFO Craig Schlesinger added, “PSYC’s commitment
to transparency and integrity will only be strengthened upon
completion of the audited 2021 financial statements. Becoming and
remaining a fully current SEC reporting company fulfills a crucial
step in the up listing process, as well as establishing trust and
credibility with the investing community as we continually execute
on our fundamental growth strategies. I believe in our team’s
commitment to tangible execution and building long term value for
PSYC, our loyal shareholders, and the communities we
serve.”
About PSYC
Corporation (OTCPink:
PSYC)
At PSYC
Corporation we are integrating media, creativity, and technology to
develop and deploy thought-provoking ideas and solutions that are
fostering and transforming the approach to some of society’s most
pressing matters.
PSYC has
expressed its intent and commitment to positioning itself at the
forefront of the psychedelic revolution and as a resource center
for discovering and understanding the latest research and business
opportunities surrounding psychedelic inspired medicines. In
conjunction with the FDA’s more open-minded approach to psychedelic
medicines, and as several major U.S. cities continue to approve the
decriminalization of psilocybin, we believe investors are
speculating that the psychedelic boom could be bigger than that of
cannabis. PSYC is your source for current investment related news
specific to psychedelic medicines and cutting-edge research
improving overall health, moving this sector into the
mainstream.
We are
dedicated to a forward-thinking approach that embraces
groundbreaking new technology and innovations and through the
vision of business development we intend to continue to evolve into
these unchartered territories as the industry leaders of the
future.
Forward-Looking Statements Disclaimer:
This press
release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. In some
cases, you can identify forward-looking statements by the following
words: "anticipate," "believe," "continue," "could," "estimate,"
"expect," "intend," "may," "ongoing," "plan," "potential,"
"predict," "project," "should," "will," "would," or the negative of
these terms or other comparable terminology, although not all
forward-looking statements contain these words. Forward-looking
statements are not a guarantee of future performance or results and
will not necessarily be accurate indications of the times at, or
by, which such performance or results will be achieved.
Forward-looking statements are based on information available at
the time the statements are made and involve known and unknown
risks, uncertainty and other factors, including the effect of
COVID-19 and the success of the current vaccine distribution, the
adverse effect of the Omicron variant, that may cause our results,
levels of activity, performance or achievements to be materially
different from the information expressed or implied by the
forward-looking statements in this press release. This press
release should be considered in light of all filings of the Company
that are disclosed on the OTC Markets.com website and is not
incorporated by reference into such
reports.
Disclaimer: PSYC Corporation does not in any way encourage or
condone the use, purchase, sale or transfer of any illegal
substances, nor do we encourage or condone partaking in any
unlawful activities. We support a harm reduction approach for the
purpose of education and promoting individual and public safety. If
you are choosing to use psychedelic substances, please do so
responsibly.
Corporate
Contact:
PSYC
Corporation (PSYC)
www.psyccorporation.com
(702)
239-1919
info@psyccorporation.com
OTCPINK:
PSYC
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Jun 2024 to Jul 2024
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Jul 2023 to Jul 2024